DIRECT-CONTACT BETWEEN T-LYMPHOCYTES AND HUMAN DERMAL FIBROBLASTS OR SYNOVIOCYTES DOWN-REGULATES TYPE-I AND TYPE-III COLLAGEN PRODUCTION VIA CELL-ASSOCIATED CYTOKINES
R. Rezzonico et al., DIRECT-CONTACT BETWEEN T-LYMPHOCYTES AND HUMAN DERMAL FIBROBLASTS OR SYNOVIOCYTES DOWN-REGULATES TYPE-I AND TYPE-III COLLAGEN PRODUCTION VIA CELL-ASSOCIATED CYTOKINES, The Journal of biological chemistry, 273(30), 1998, pp. 18720-18728
In many inflammatory diseases where tissue remodeling occurs, T cells
are in close contact with mesenchymal cells. We investigated the effec
t of direct cell-cell contact between peripheral blood T lymphocytes o
r HUT-78 lymphoma cells and dermal fibroblasts or synoviocytes on the
deposition of the major extracellular matrix components: types I and I
II collagen. Incubation of dermal fibroblasts and synoviocytes with pl
asma membrane preparations from resting T cells slightly increased the
production of collagen I but did not significantly affect that of col
lagen III. Conversely, direct contact with either plasma membranes or
fixed phytohemagglutinin/phorbol myristate acetate activated T cells m
arkedly inhibited the synthesis of types I and III collagen by 60-70%
in untreated dermal fibroblasts and synoviocytes and by 85% in transfo
rming growth factor beta-stimulated fibroblasts. This decrease of coll
agen synthesis was abrogated when fixed T cells were separated physica
lly hom fibroblasts, demonstrating that direct contact between the two
cell types was necessary. This inhibition was associated with a marke
d decrease in steady-state levels of pro-alpha 1(I) and pro-alpha 1(II
I) collagen mRNAs. T cell contact decreased the transcription rate but
did not significantly alter the stability of the alpha 1(I) and alpha
1(III) transcripts. Finally, using neutralizing antibodies or cytokin
e inhibitors we provide evidence that this inhibition of extracellular
matrix production mediated by T cell contact was partially due to add
itive effects of T cell membrane-associated interferon gamma, tumor ne
crosis factor alpha, and interleukin-1 alpha.